ILMN
32
-3
UHS
54
3
AVGO
20
-5
AMP
69
-3
NTAP
64
2
CF
59
3
EQT
59
2
BEN
45
3
HON
65
-2
XYL
37
2
LLY
39
9
ETR
68
3
APA
21
2
A
36
2
XEL
67
2
COP
56
2
QCOM
48
-7
LB
34
8
BBY
40
3
DE
46
3
ILMN
32
-3
UHS
54
3
AVGO
20
-5
AMP
69
-3
NTAP
64
2
CF
59
3
EQT
59
2
BEN
45
3
HON
65
-2
XYL
37
2
LLY
39
9
ETR
68
3
APA
21
2
A
36
2
XEL
67
2
COP
56
2
QCOM
48
-7
LB
34
8
BBY
40
3
DE
46
3
Financhill
Back

Axsome Therapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61

AXSM
Axsome Therapeutics

Last Price:
98.18
Seasonality Move:
43.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Axsome Therapeutics Price Quote

$98.18
+3.58 (+3.78%)
(Updated: November 21, 2024 at 5:55 PM ET)

Axsome Therapeutics Key Stats

Buy
61
Axsome Therapeutics (AXSM) is a Buy
Day range:
$94.24 - $96.92
52-week range:
$58.61 - $105.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.01
P/B ratio:
48.23%
Volume:
373K
Avg. volume:
492.6K
1-year change:
57.56%
Market cap:
$4.5B
Revenue:
$270.6M
EPS:
$-6.53

How Much Does Axsome Therapeutics Make?

Is Axsome Therapeutics Growing As A Company?

  • What Is Axsome Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.81%
  • What Is Axsome Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Axsome Therapeutics Stock Price Performance

What Is Axsome Therapeutics 52-Week High & Low?

Axsome Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Axsome Therapeutics?

Is Axsome Therapeutics Cash Flow Positive?

  • What Is AXSM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$132.6M
  • What Is Axsome Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $43.6M
  • What Is Axsome Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$247K

Axsome Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    AXSM return on invested capital is -91.79%
  • What Is Axsome Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -54.66%
  • What Is AXSM Return On Equity?
    ROE is a measure of profitability and is -194.28%

Axsome Therapeutics Earnings Date & Stock Price

Axsome Therapeutics Competitors

Axsome Therapeutics Dividend Yield

Axsome Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3.49%
Revenue: 81.27% 6.82%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 129.41
Upside from Last Price: 36.8%

Major Shareholders

  • How many AXSM shares are owned by institutional investors?
    57.8M AXSM shares are owned by institutional investors
  • How many AXSM shares are owned by insiders?
    209.5K AXSM shares are owned by insiders